BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

554 related articles for article (PubMed ID: 20393147)

  • 1. Spectrum of HNF1A somatic mutations in hepatocellular adenoma differs from that in patients with MODY3 and suggests genotoxic damage.
    Jeannot E; Mellottee L; Bioulac-Sage P; Balabaud C; Scoazec JY; Tran Van Nhieu J; Bacq Y; Michalak S; Buob D; ; Laurent-Puig P; Rusyn I; Zucman-Rossi J
    Diabetes; 2010 Jul; 59(7):1836-44. PubMed ID: 20393147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary hepatocellular adenoma due to biallelic HNF1A mutations and its co-occurrence with MODY 3: case-report and review of the literature.
    Fu J; Wang T; Zhai X; Xiao X
    Endocrine; 2020 Mar; 67(3):544-551. PubMed ID: 31754975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary hepatocellular neoplasms in a MODY3 family with a novel HNF1A germline mutation.
    Willson JS; Godwin TD; Wiggins GA; Guilford PJ; McCall JL
    J Hepatol; 2013 Oct; 59(4):904-7. PubMed ID: 23707370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis of hepatocellular adenoma in men before onset of diabetes in HNF1A-MODY: Watch out for winkers.
    Haring MPD; Vriesendorp TM; Klein Wassink-Ruiter JS; de Haas RJ; Gouw ASH; de Meijer VE
    Liver Int; 2019 Nov; 39(11):2042-2045. PubMed ID: 31483937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The spectrum of HNF1A gene mutations in Greek patients with MODY3: relative frequency and identification of seven novel germline mutations.
    Tatsi C; Kanaka-Gantenbein C; Vazeou-Gerassimidi A; Chrysis D; Delis D; Tentolouris N; Dacou-Voutetakis C; Chrousos GP; Sertedaki A
    Pediatr Diabetes; 2013 Nov; 14(7):526-34. PubMed ID: 23517481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular characterization of hepatocellular adenomas developed in patients with glycogen storage disease type I.
    Calderaro J; Labrune P; Morcrette G; Rebouissou S; Franco D; Prévot S; Quaglia A; Bedossa P; Libbrecht L; Terracciano L; Smit GP; Bioulac-Sage P; Zucman-Rossi J
    J Hepatol; 2013 Feb; 58(2):350-7. PubMed ID: 23046672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver adenomatosis in patients with hepatocyte nuclear factor-1 alpha maturity onset diabetes of the young (HNF1A-MODY): Clinical, radiological and pathological characteristics in a French series.
    Haddouche A; Bellanne-Chantelot C; Rod A; Fournier L; Chiche L; Gautier JF; Timsit J; Laboureau S; Chaillous L; Valero R; Larger E; Jeandidier N; Wilhelm JM; Popelier M; Guillausseau PJ; Thivolet C; Lecomte P; Benhamou PY; Reznik Y
    J Diabetes; 2020 Jan; 12(1):48-57. PubMed ID: 31166087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocellular Adenoma: Report of 2 Cases That Highlight the Relevance of Phenotype-Genotype Correlation in the Pediatric Population.
    Jiao J; Finberg KE; Jain D; Morotti R
    Pediatr Dev Pathol; 2023; 26(4):394-403. PubMed ID: 37334553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocellular adenoma classification: a comparative evaluation of immunohistochemistry and targeted mutational analysis.
    Margolskee E; Bao F; de Gonzalez AK; Moreira RK; Lagana S; Sireci AN; Sepulveda AR; Remotti H; Lefkowitch JH; Salomao M
    Diagn Pathol; 2016 Mar; 11():27. PubMed ID: 26961851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening of HNF1A and HNF4A mutation and clinical phenotype analysis in a large cohort of Chinese patients with maturity-onset diabetes of the young.
    Wang X; Wang T; Yu M; Zhang H; Ping F; Zhang Q; Xu J; Feng K; Xiao X
    Acta Diabetol; 2019 Mar; 56(3):281-288. PubMed ID: 30293189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatic HNF1A mutations in the malignant transformation of hepatocellular adenomas: a retrospective analysis of data from MSK-IMPACT and TCGA.
    Hechtman JF; Abou-Alfa GK; Stadler ZK; Mandelker DL; Roehrl MHA; Zehir A; Vakiani E; Middha S; Klimstra DS; Shia J
    Hum Pathol; 2019 Jan; 83():1-6. PubMed ID: 30121369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of hepatocyte nuclear factor 1alpha function in human hepatocellular adenomas leads to aberrant activation of signaling pathways involved in tumorigenesis.
    Pelletier L; Rebouissou S; Paris A; Rathahao-Paris E; Perdu E; Bioulac-Sage P; Imbeaud S; Zucman-Rossi J
    Hepatology; 2010 Feb; 51(2):557-66. PubMed ID: 20041408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Classification of Hepatocellular Adenoma Associates With Risk Factors, Bleeding, and Malignant Transformation.
    Nault JC; Couchy G; Balabaud C; Morcrette G; Caruso S; Blanc JF; Bacq Y; Calderaro J; Paradis V; Ramos J; Scoazec JY; Gnemmi V; Sturm N; Guettier C; Fabre M; Savier E; Chiche L; Labrune P; Selves J; Wendum D; Pilati C; Laurent A; De Muret A; Le Bail B; Rebouissou S; Imbeaud S; ; Bioulac-Sage P; Letouzé E; Zucman-Rossi J
    Gastroenterology; 2017 Mar; 152(4):880-894.e6. PubMed ID: 27939373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-function studies of HNF1A (MODY3) gene mutations in South Indian patients with monogenic diabetes.
    Balamurugan K; Bjørkhaug L; Mahajan S; Kanthimathi S; Njølstad PR; Srinivasan N; Mohan V; Radha V
    Clin Genet; 2016 Dec; 90(6):486-495. PubMed ID: 26853433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial liver adenomatosis associated with hepatocyte nuclear factor 1alpha inactivation.
    Bacq Y; Jacquemin E; Balabaud C; Jeannot E; Scotto B; Branchereau S; Laurent C; Bourlier P; Pariente D; de Muret A; Fabre M; Bioulac-Sage P; Zucman-Rossi J
    Gastroenterology; 2003 Nov; 125(5):1470-5. PubMed ID: 14598263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular classification of hepatocellular adenoma in clinical practice.
    Nault JC; Paradis V; Cherqui D; Vilgrain V; Zucman-Rossi J
    J Hepatol; 2017 Nov; 67(5):1074-1083. PubMed ID: 28733222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hepatocyte nuclear factor 1α-inactivated hepatocellular adenomatosis in a patient with maturity-onset diabetes of the young type 3: case report and literature review].
    Hirata E; Shimizu S; Umeda S; Kobayashi T; Nakano M; Higuchi H; Serizawa H; Iwasaki N; Morinaga S; Tsunematsu S
    Nihon Shokakibyo Gakkai Zasshi; 2015; 112(9):1696-704. PubMed ID: 26346360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous occurrence of focal nodular hyperplasia and HNF1A-inactivated hepatocellular adenoma: a collision tumor simulating a composite FNH-HCA.
    Shih A; Lauwers GY; Balabaud C; Bioulac-Sage P; Misdraji J
    Am J Surg Pathol; 2015 Sep; 39(9):1296-300. PubMed ID: 26274031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of CYP1B1 germ line mutations with hepatocyte nuclear factor 1alpha-mutated hepatocellular adenoma.
    Jeannot E; Poussin K; Chiche L; Bacq Y; Sturm N; Scoazec JY; Buffet C; Van Nhieu JT; Bellanné-Chantelot C; de Toma C; Laurent-Puig P; Bioulac-Sage P; Zucman-Rossi J
    Cancer Res; 2007 Mar; 67(6):2611-6. PubMed ID: 17363580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The HNF1A mutant Ala180Val: Clinical challenges in determining causality of a rare HNF1A variant in familial diabetes.
    Sagen JV; Bjørkhaug L; Haukanes BI; Grevle L; Molnes J; Nedrebø BG; Søvik O; Njølstad PR; Johansson S; Molven A
    Diabetes Res Clin Pract; 2017 Nov; 133():142-149. PubMed ID: 28934671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.